Report Cover

Global Vancomycin Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    Daptomycin
    Linezolid
    Quinupristin
    Ampicillin
    Chloramphenicol
    Others

Segment by Application
    Sepsis
    Lung Infection
    Skin Soft Tissue Infection
    Colitis & Intestinal Inflammation
    To Prevent Infection

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Pfizer
    Eli Lilly and Company
    CJ CheilJedang
    Xellia Pharmaceuticals ApS
    VIANEX
    Alchemia Limited
    Alvogen
    Aphios Corporation
    Cellceutix Corporation
    Enanta Pharmaceuticals
    Helix BioMedix
    LegoChem Biosciences
    Lytix Biopharma
    MGB Biopharma Limited
    Microbiotix.
    MicuRx Pharmaceuticals
    Nabriva Therapeutics
    NovaBay Pharmaceuticals
    NovoBiotic Pharmaceuticals
    Oragenics
    Sealife Pharma
    Taiwan Zhengde Pharmaceutical
    Zhejiang Pharmaceutical
    Zhejiang Haizheng Pharmaceutical
    North China Pharmaceutical
    Shenwei Pharmaceutical
1 Vancomycin Market Overview
    1.1 Product Overview and Scope of Vancomycin
    1.2 Vancomycin Segment by Type
        1.2.1 Global Vancomycin Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Daptomycin
        1.2.3 Linezolid
        1.2.4 Quinupristin
        1.2.5 Ampicillin
        1.2.6 Chloramphenicol
        1.2.7 Others
    1.3 Vancomycin Segment by Application
        1.3.1 Vancomycin Sales Comparison by Application: (2021-2027)
        1.3.2 Sepsis
        1.3.3 Lung Infection
        1.3.4 Skin Soft Tissue Infection
        1.3.5 Colitis & Intestinal Inflammation
        1.3.6 To Prevent Infection
    1.4 Global Vancomycin Market Size Estimates and Forecasts
        1.4.1 Global Vancomycin Revenue 2016-2027
        1.4.2 Global Vancomycin Sales 2016-2027
        1.4.3 Vancomycin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Vancomycin Market Competition by Manufacturers
    2.1 Global Vancomycin Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Vancomycin Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Vancomycin Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Vancomycin Manufacturing Sites, Area Served, Product Type
    2.5 Vancomycin Market Competitive Situation and Trends
        2.5.1 Vancomycin Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Vancomycin Players Market Share by Revenue
        2.5.3 Global Vancomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Vancomycin Retrospective Market Scenario by Region
    3.1 Global Vancomycin Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Vancomycin Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Vancomycin Market Facts & Figures by Country
        3.3.1 North America Vancomycin Sales by Country
        3.3.2 North America Vancomycin Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Vancomycin Market Facts & Figures by Country
        3.4.1 Europe Vancomycin Sales by Country
        3.4.2 Europe Vancomycin Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Vancomycin Market Facts & Figures by Region
        3.5.1 Asia Pacific Vancomycin Sales by Region
        3.5.2 Asia Pacific Vancomycin Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Vancomycin Market Facts & Figures by Country
        3.6.1 Latin America Vancomycin Sales by Country
        3.6.2 Latin America Vancomycin Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Vancomycin Market Facts & Figures by Country
        3.7.1 Middle East and Africa Vancomycin Sales by Country
        3.7.2 Middle East and Africa Vancomycin Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Vancomycin Historic Market Analysis by Type
    4.1 Global Vancomycin Sales Market Share by Type (2016-2021)
    4.2 Global Vancomycin Revenue Market Share by Type (2016-2021)
    4.3 Global Vancomycin Price by Type (2016-2021)

5 Global Vancomycin Historic Market Analysis by Application
    5.1 Global Vancomycin Sales Market Share by Application (2016-2021)
    5.2 Global Vancomycin Revenue Market Share by Application (2016-2021)
    5.3 Global Vancomycin Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Pfizer
        6.1.1 Pfizer Corporation Information
        6.1.2 Pfizer Description and Business Overview
        6.1.3 Pfizer Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Pfizer Product Portfolio
        6.1.5 Pfizer Recent Developments/Updates
    6.2 Eli Lilly and Company
        6.2.1 Eli Lilly and Company Corporation Information
        6.2.2 Eli Lilly and Company Description and Business Overview
        6.2.3 Eli Lilly and Company Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 Eli Lilly and Company Product Portfolio
        6.2.5 Eli Lilly and Company Recent Developments/Updates
    6.3 CJ CheilJedang
        6.3.1 CJ CheilJedang Corporation Information
        6.3.2 CJ CheilJedang Description and Business Overview
        6.3.3 CJ CheilJedang Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 CJ CheilJedang Product Portfolio
        6.3.5 CJ CheilJedang Recent Developments/Updates
    6.4 Xellia Pharmaceuticals ApS
        6.4.1 Xellia Pharmaceuticals ApS Corporation Information
        6.4.2 Xellia Pharmaceuticals ApS Description and Business Overview
        6.4.3 Xellia Pharmaceuticals ApS Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Xellia Pharmaceuticals ApS Product Portfolio
        6.4.5 Xellia Pharmaceuticals ApS Recent Developments/Updates
    6.5 VIANEX
        6.5.1 VIANEX Corporation Information
        6.5.2 VIANEX Description and Business Overview
        6.5.3 VIANEX Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 VIANEX Product Portfolio
        6.5.5 VIANEX Recent Developments/Updates
    6.6 Alchemia Limited
        6.6.1 Alchemia Limited Corporation Information
        6.6.2 Alchemia Limited Description and Business Overview
        6.6.3 Alchemia Limited Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 Alchemia Limited Product Portfolio
        6.6.5 Alchemia Limited Recent Developments/Updates
    6.7 Alvogen
        6.6.1 Alvogen Corporation Information
        6.6.2 Alvogen Description and Business Overview
        6.6.3 Alvogen Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Alvogen Product Portfolio
        6.7.5 Alvogen Recent Developments/Updates
    6.8 Aphios Corporation
        6.8.1 Aphios Corporation Corporation Information
        6.8.2 Aphios Corporation Description and Business Overview
        6.8.3 Aphios Corporation Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Aphios Corporation Product Portfolio
        6.8.5 Aphios Corporation Recent Developments/Updates
    6.9 Cellceutix Corporation
        6.9.1 Cellceutix Corporation Corporation Information
        6.9.2 Cellceutix Corporation Description and Business Overview
        6.9.3 Cellceutix Corporation Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Cellceutix Corporation Product Portfolio
        6.9.5 Cellceutix Corporation Recent Developments/Updates
    6.10 Enanta Pharmaceuticals
        6.10.1 Enanta Pharmaceuticals Corporation Information
        6.10.2 Enanta Pharmaceuticals Description and Business Overview
        6.10.3 Enanta Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Enanta Pharmaceuticals Product Portfolio
        6.10.5 Enanta Pharmaceuticals Recent Developments/Updates
    6.11 Helix BioMedix
        6.11.1 Helix BioMedix Corporation Information
        6.11.2 Helix BioMedix Vancomycin Description and Business Overview
        6.11.3 Helix BioMedix Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 Helix BioMedix Product Portfolio
        6.11.5 Helix BioMedix Recent Developments/Updates
    6.12 LegoChem Biosciences
        6.12.1 LegoChem Biosciences Corporation Information
        6.12.2 LegoChem Biosciences Vancomycin Description and Business Overview
        6.12.3 LegoChem Biosciences Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 LegoChem Biosciences Product Portfolio
        6.12.5 LegoChem Biosciences Recent Developments/Updates
    6.13 Lytix Biopharma
        6.13.1 Lytix Biopharma Corporation Information
        6.13.2 Lytix Biopharma Vancomycin Description and Business Overview
        6.13.3 Lytix Biopharma Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Lytix Biopharma Product Portfolio
        6.13.5 Lytix Biopharma Recent Developments/Updates
    6.14 MGB Biopharma Limited
        6.14.1 MGB Biopharma Limited Corporation Information
        6.14.2 MGB Biopharma Limited Vancomycin Description and Business Overview
        6.14.3 MGB Biopharma Limited Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 MGB Biopharma Limited Product Portfolio
        6.14.5 MGB Biopharma Limited Recent Developments/Updates
    6.15 Microbiotix.
        6.15.1 Microbiotix. Corporation Information
        6.15.2 Microbiotix. Vancomycin Description and Business Overview
        6.15.3 Microbiotix. Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Microbiotix. Product Portfolio
        6.15.5 Microbiotix. Recent Developments/Updates
    6.16 MicuRx Pharmaceuticals
        6.16.1 MicuRx Pharmaceuticals Corporation Information
        6.16.2 MicuRx Pharmaceuticals Vancomycin Description and Business Overview
        6.16.3 MicuRx Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 MicuRx Pharmaceuticals Product Portfolio
        6.16.5 MicuRx Pharmaceuticals Recent Developments/Updates
    6.17 Nabriva Therapeutics
        6.17.1 Nabriva Therapeutics Corporation Information
        6.17.2 Nabriva Therapeutics Vancomycin Description and Business Overview
        6.17.3 Nabriva Therapeutics Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Nabriva Therapeutics Product Portfolio
        6.17.5 Nabriva Therapeutics Recent Developments/Updates
    6.18 NovaBay Pharmaceuticals
        6.18.1 NovaBay Pharmaceuticals Corporation Information
        6.18.2 NovaBay Pharmaceuticals Vancomycin Description and Business Overview
        6.18.3 NovaBay Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 NovaBay Pharmaceuticals Product Portfolio
        6.18.5 NovaBay Pharmaceuticals Recent Developments/Updates
    6.19 NovoBiotic Pharmaceuticals
        6.19.1 NovoBiotic Pharmaceuticals Corporation Information
        6.19.2 NovoBiotic Pharmaceuticals Vancomycin Description and Business Overview
        6.19.3 NovoBiotic Pharmaceuticals Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 NovoBiotic Pharmaceuticals Product Portfolio
        6.19.5 NovoBiotic Pharmaceuticals Recent Developments/Updates
    6.20 Oragenics
        6.20.1 Oragenics Corporation Information
        6.20.2 Oragenics Vancomycin Description and Business Overview
        6.20.3 Oragenics Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Oragenics Product Portfolio
        6.20.5 Oragenics Recent Developments/Updates
    6.21 Sealife Pharma
        6.21.1 Sealife Pharma Corporation Information
        6.21.2 Sealife Pharma Vancomycin Description and Business Overview
        6.21.3 Sealife Pharma Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Sealife Pharma Product Portfolio
        6.21.5 Sealife Pharma Recent Developments/Updates
    6.22 Taiwan Zhengde Pharmaceutical
        6.22.1 Taiwan Zhengde Pharmaceutical Corporation Information
        6.22.2 Taiwan Zhengde Pharmaceutical Vancomycin Description and Business Overview
        6.22.3 Taiwan Zhengde Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 Taiwan Zhengde Pharmaceutical Product Portfolio
        6.22.5 Taiwan Zhengde Pharmaceutical Recent Developments/Updates
    6.23 Zhejiang Pharmaceutical
        6.23.1 Zhejiang Pharmaceutical Corporation Information
        6.23.2 Zhejiang Pharmaceutical Vancomycin Description and Business Overview
        6.23.3 Zhejiang Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.23.4 Zhejiang Pharmaceutical Product Portfolio
        6.23.5 Zhejiang Pharmaceutical Recent Developments/Updates
    6.24 Zhejiang Haizheng Pharmaceutical
        6.24.1 Zhejiang Haizheng Pharmaceutical Corporation Information
        6.24.2 Zhejiang Haizheng Pharmaceutical Vancomycin Description and Business Overview
        6.24.3 Zhejiang Haizheng Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.24.4 Zhejiang Haizheng Pharmaceutical Product Portfolio
        6.24.5 Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
    6.25 North China Pharmaceutical
        6.25.1 North China Pharmaceutical Corporation Information
        6.25.2 North China Pharmaceutical Vancomycin Description and Business Overview
        6.25.3 North China Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.25.4 North China Pharmaceutical Product Portfolio
        6.25.5 North China Pharmaceutical Recent Developments/Updates
    6.26 Shenwei Pharmaceutical
        6.26.1 Shenwei Pharmaceutical Corporation Information
        6.26.2 Shenwei Pharmaceutical Vancomycin Description and Business Overview
        6.26.3 Shenwei Pharmaceutical Vancomycin Sales, Revenue and Gross Margin (2016-2021)
        6.26.4 Shenwei Pharmaceutical Product Portfolio
        6.26.5 Shenwei Pharmaceutical Recent Developments/Updates

7 Vancomycin Manufacturing Cost Analysis
    7.1 Vancomycin Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Vancomycin
    7.4 Vancomycin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Vancomycin Distributors List
    8.3 Vancomycin Customers

9 Vancomycin Market Dynamics
    9.1 Vancomycin Industry Trends
    9.2 Vancomycin Growth Drivers
    9.3 Vancomycin Market Challenges
    9.4 Vancomycin Market Restraints

10 Global Market Forecast
    10.1 Vancomycin Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Vancomycin by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Vancomycin by Type (2022-2027)
    10.2 Vancomycin Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Vancomycin by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Vancomycin by Application (2022-2027)
    10.3 Vancomycin Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Vancomycin by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Vancomycin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Vancomycin Sales (KG) Growth Rate Comparison by Type (2021-2027) Table 2. Global Vancomycin Sales (KG) Comparison by Application (2021-2027) Table 3. Global Vancomycin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Vancomycin Covered in This Study Table 5. Global Vancomycin Sales (KG) of Key Manufacturers (2016-2021) Table 6. Global Vancomycin Sales Share by Manufacturers (2016-2021) Table 7. Global Vancomycin Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Vancomycin Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Vancomycin Average Price (US$/G) of Key Manufacturers (2016-2021) Table 10. Manufacturers Vancomycin Manufacturing Sites and Area Served Table 11. Manufacturers Vancomycin Product Type Table 12. Global Vancomycin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Vancomycin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vancomycin as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Vancomycin Sales by Region (2016-2021) & (KG) Table 16. Global Vancomycin Sales Market Share by Region (2016-2021) Table 17. Global Vancomycin Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Vancomycin Sales by Country (2016-2021) & (KG) Table 19. North America Vancomycin Sales Market Share by Country (2016-2021) Table 20. North America Vancomycin Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Vancomycin Revenue Market Share by Country (2016-2021) Table 22. Europe Vancomycin Sales by Country (2016-2021) & (KG) Table 23. Europe Vancomycin Sales Market Share by Country (2016-2021) Table 24. Europe Vancomycin Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Vancomycin Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Vancomycin Sales by Region (2016-2021) & (KG) Table 27. Asia Pacific Vancomycin Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Vancomycin Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Vancomycin Revenue Market Share by Region (2016-2021) Table 30. Latin America Vancomycin Sales by Country (2016-2021) & (KG) Table 31. Latin America Vancomycin Sales Market Share by Country (2016-2021) Table 32. Latin America Vancomycin Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Vancomycin Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Vancomycin Sales by Country (2016-2021) & (KG) Table 35. Middle East and Africa Vancomycin Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Vancomycin Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Vancomycin Revenue Market Share by Country (2016-2021) Table 38. Global Vancomycin Sales (KG) by Type (2016-2021) Table 39. Global Vancomycin Sales Market Share by Type (2016-2021) Table 40. Global Vancomycin Revenue (Million US$) by Type (2016-2021) Table 41. Global Vancomycin Revenue Share by Type (2016-2021) Table 42. Global Vancomycin Price (US$/G) by Type (2016-2021) Table 43. Global Vancomycin Sales (KG) by Application (2016-2021) Table 44. Global Vancomycin Sales Market Share by Application (2016-2021) Table 45. Global Vancomycin Revenue (Million US$) by Application (2016-2021) Table 46. Global Vancomycin Revenue Share by Application (2016-2021) Table 47. Global Vancomycin Price (US$/G) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 51. Pfizer Vancomycin Product Table 52. Pfizer Recent Developments/Updates Table 53. Eli Lilly and Company Corporation Information Table 54. Eli Lilly and Company Description and Business Overview Table 55. Eli Lilly and Company Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 56. Eli Lilly and Company Vancomycin Product Table 57. Eli Lilly and Company Recent Developments/Updates Table 58. CJ CheilJedang Corporation Information Table 59. CJ CheilJedang Description and Business Overview Table 60. CJ CheilJedang Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 61. CJ CheilJedang Vancomycin Product Table 62. CJ CheilJedang Recent Developments/Updates Table 63. Xellia Pharmaceuticals ApS Corporation Information Table 64. Xellia Pharmaceuticals ApS Description and Business Overview Table 65. Xellia Pharmaceuticals ApS Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 66. Xellia Pharmaceuticals ApS Vancomycin Product Table 67. Xellia Pharmaceuticals ApS Recent Developments/Updates Table 68. VIANEX Corporation Information Table 69. VIANEX Description and Business Overview Table 70. VIANEX Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 71. VIANEX Vancomycin Product Table 72. VIANEX Recent Developments/Updates Table 73. Alchemia Limited Corporation Information Table 74. Alchemia Limited Description and Business Overview Table 75. Alchemia Limited Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 76. Alchemia Limited Vancomycin Product Table 77. Alchemia Limited Recent Developments/Updates Table 78. Alvogen Corporation Information Table 79. Alvogen Description and Business Overview Table 80. Alvogen Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 81. Alvogen Vancomycin Product Table 82. Alvogen Recent Developments/Updates Table 83. Aphios Corporation Corporation Information Table 84. Aphios Corporation Description and Business Overview Table 85. Aphios Corporation Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 86. Aphios Corporation Vancomycin Product Table 87. Aphios Corporation Recent Developments/Updates Table 88. Cellceutix Corporation Corporation Information Table 89. Cellceutix Corporation Description and Business Overview Table 90. Cellceutix Corporation Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 91. Cellceutix Corporation Vancomycin Product Table 92. Cellceutix Corporation Recent Developments/Updates Table 93. Enanta Pharmaceuticals Corporation Information Table 94. Enanta Pharmaceuticals Description and Business Overview Table 95. Enanta Pharmaceuticals Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 96. Enanta Pharmaceuticals Vancomycin Product Table 97. Enanta Pharmaceuticals Recent Developments/Updates Table 98. Helix BioMedix Corporation Information Table 99. Helix BioMedix Description and Business Overview Table 100. Helix BioMedix Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 101. Helix BioMedix Vancomycin Product Table 102. Helix BioMedix Recent Developments/Updates Table 103. LegoChem Biosciences Corporation Information Table 104. LegoChem Biosciences Description and Business Overview Table 105. LegoChem Biosciences Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 106. LegoChem Biosciences Vancomycin Product Table 107. LegoChem Biosciences Recent Developments/Updates Table 108. Lytix Biopharma Corporation Information Table 109. Lytix Biopharma Description and Business Overview Table 110. Lytix Biopharma Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 111. Lytix Biopharma Vancomycin Product Table 112. Lytix Biopharma Recent Developments/Updates Table 113. MGB Biopharma Limited Corporation Information Table 114. MGB Biopharma Limited Description and Business Overview Table 115. MGB Biopharma Limited Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 116. MGB Biopharma Limited Vancomycin Product Table 117. MGB Biopharma Limited Recent Developments/Updates Table 118. Microbiotix. Corporation Information Table 119. Microbiotix. Description and Business Overview Table 120. Microbiotix. Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 121. Microbiotix. Vancomycin Product Table 122. Microbiotix. Recent Developments/Updates Table 123. MicuRx Pharmaceuticals Corporation Information Table 124. MicuRx Pharmaceuticals Description and Business Overview Table 125. MicuRx Pharmaceuticals Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 126. MicuRx Pharmaceuticals Vancomycin Product Table 127. MicuRx Pharmaceuticals Recent Developments/Updates Table 128. Nabriva Therapeutics Corporation Information Table 129. Nabriva Therapeutics Description and Business Overview Table 130. Nabriva Therapeutics Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 131. Nabriva Therapeutics Vancomycin Product Table 132. Nabriva Therapeutics Recent Developments/Updates Table 133. NovaBay Pharmaceuticals Corporation Information Table 134. NovaBay Pharmaceuticals Description and Business Overview Table 135. NovaBay Pharmaceuticals Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 136. NovaBay Pharmaceuticals Vancomycin Product Table 137. NovaBay Pharmaceuticals Recent Developments/Updates Table 138. NovoBiotic Pharmaceuticals Corporation Information Table 139. NovoBiotic Pharmaceuticals Description and Business Overview Table 140. NovoBiotic Pharmaceuticals Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 141. NovoBiotic Pharmaceuticals Vancomycin Product Table 142. NovoBiotic Pharmaceuticals Recent Developments/Updates Table 143. Oragenics Corporation Information Table 144. Oragenics Description and Business Overview Table 145. Oragenics Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 146. Oragenics Vancomycin Product Table 147. Oragenics Recent Developments/Updates Table 148. Sealife Pharma Corporation Information Table 149. Sealife Pharma Description and Business Overview Table 150. Sealife Pharma Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 151. Sealife Pharma Vancomycin Product Table 152. Sealife Pharma Recent Developments/Updates Table 153. Taiwan Zhengde Pharmaceutical Corporation Information Table 154. Taiwan Zhengde Pharmaceutical Description and Business Overview Table 155. Taiwan Zhengde Pharmaceutical Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 156. Taiwan Zhengde Pharmaceutical Vancomycin Product Table 157. Taiwan Zhengde Pharmaceutical Recent Developments/Updates Table 158. Zhejiang Pharmaceutical Corporation Information Table 159. Zhejiang Pharmaceutical Description and Business Overview Table 160. Zhejiang Pharmaceutical Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 161. Zhejiang Pharmaceutical Vancomycin Product Table 162. Zhejiang Pharmaceutical Recent Developments/Updates Table 163. Zhejiang Haizheng Pharmaceutical Corporation Information Table 164. Zhejiang Haizheng Pharmaceutical Description and Business Overview Table 165. Zhejiang Haizheng Pharmaceutical Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 166. Zhejiang Haizheng Pharmaceutical Vancomycin Product Table 167. Zhejiang Haizheng Pharmaceutical Recent Developments/Updates Table 168. North China Pharmaceutical Corporation Information Table 169. North China Pharmaceutical Description and Business Overview Table 170. North China Pharmaceutical Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 171. North China Pharmaceutical Vancomycin Product Table 172. North China Pharmaceutical Recent Developments/Updates Table 173. Shenwei Pharmaceutical Corporation Information Table 174. Shenwei Pharmaceutical Description and Business Overview Table 175. Shenwei Pharmaceutical Vancomycin Sales (KG), Revenue (Million US$), Price (US$/G) and Gross Margin (2016-2021) Table 176. Shenwei Pharmaceutical Vancomycin Product Table 177. Shenwei Pharmaceutical Recent Developments/Updates Table 178. Production Base and Market Concentration Rate of Raw Material Table 179. Key Suppliers of Raw Materials Table 180. Vancomycin Distributors List Table 181. Vancomycin Customers List Table 182. Vancomycin Market Trends Table 183. Vancomycin Growth Drivers Table 184. Vancomycin Market Restraints Table 185. Global Vancomycin Sales Forecast by Type (2022-2027) & (KG) Table 186. Global Vancomycin Sales Market Share Forecast by Type (2022-2027) Table 187. Global Vancomycin Revenue Forecast by Type (2022-2027) & (US$ Million) Table 188. Global Vancomycin Revenue Market Share Forecast by Type (2022-2027) Table 189. Global Vancomycin Sales Forecast by Application (2022-2027) & (KG) Table 190. Global Vancomycin Sales Market Share Forecast by Application (2022-2027) Table 191. Global Vancomycin Revenue Forecast by Application (2022-2027) & (US$ Million) Table 192. Global Vancomycin Revenue Market Share Forecast by Application (2022-2027) Table 193. Global Vancomycin Sales Forecast by Region (2022-2027) & (KG) Table 194. Global Vancomycin Sales Market Share Forecast by Region (2022-2027) Table 195. Global Vancomycin Revenue Forecast by Region (2022-2027) & (US$ Million) Table 196. Global Vancomycin Revenue Market Share Forecast by Region (2022-2027) Table 197. Research Programs/Design for This Report Table 198. Key Data Information from Secondary Sources Table 199. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Vancomycin Figure 2. Global Vancomycin Market Share by Type in 2020 & 2027 Figure 3. Daptomycin Product Picture Figure 4. Linezolid Product Picture Figure 5. Quinupristin Product Picture Figure 6. Ampicillin Product Picture Figure 7. Chloramphenicol Product Picture Figure 8. Others Product Picture Figure 9. Global Vancomycin Market Share by Application in 2020 & 2027 Figure 10. Sepsis Figure 11. Lung Infection Figure 12. Skin Soft Tissue Infection Figure 13. Colitis & Intestinal Inflammation Figure 14. To Prevent Infection Figure 15. Global Vancomycin Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Vancomycin Market Size 2016-2027 (US$ Million) Figure 17. Global Vancomycin Sales 2016-2027 (KG) Figure 18. Global Vancomycin Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 19. Vancomycin Sales Share by Manufacturers in 2020 Figure 20. Global Vancomycin Revenue Share by Manufacturers in 2020 Figure 21. The Global 5 and 10 Largest Vancomycin Players: Market Share by Revenue in 2020 Figure 22. Vancomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 23. Global Vancomycin Sales Market Share by Region (2016-2021) Figure 24. Global Vancomycin Sales Market Share by Region in 2020 Figure 25. Global Vancomycin Revenue Market Share by Region (2016-2021) Figure 26. Global Vancomycin Revenue Market Share by Region in 2020 Figure 27. U.S. Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Canada Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Germany Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. France Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. U.K. Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Italy Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Russia Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. China Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Japan Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. South Korea Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. India Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Australia Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Taiwan Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Indonesia Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Thailand Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Malaysia Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Philippines Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Vietnam Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Mexico Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Brazil Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Argentina Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Turkey Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Saudi Arabia Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. UAE Vancomycin Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Sales Market Share of Vancomycin by Type (2016-2021) Figure 52. Sales Market Share of Vancomycin by Application (2016-2021) Figure 53. Sales Market Share of Vancomycin by Application in 2020 Figure 54. Revenue Share of Vancomycin by Application (2016-2021) Figure 55. Revenue Share of Vancomycin by Application in 2020 Figure 56. Manufacturing Cost Structure of Vancomycin Figure 57. Manufacturing Process Analysis of Vancomycin Figure 58. Vancomycin Industrial Chain Analysis Figure 59. Channels of Distribution Figure 60. Distributors Profiles Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us